Verdiva Bio (private company)
See something wrong or missing? Let us know
Offices:London
Business model:B2B
Verdiva Bio is a British developer of GLP-1 drugs for obesity
Investors:
we tracked 7 investors
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
values in USD
Investments 410M
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain